13F-HR filed by DIADEMA PARTNERS LP
DIADEMA PARTNERS LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 95 holding rows worth $328,219,079.
- Accession
- 0001892688-25-000149
- Filer
- CIK 2026172
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 96 entries on the cover page, a total value of $328,219,079 stated on the cover page (in dollars after the unit check, H1), rows summing to $328,219,079 with VALUE read as dollars as filed, 13F file number 028-25172. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | 834203309 | COM | 284,152 | $23,806,255 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 62,100 | $17,338,941 | dollars as filed | put |
| Eli Lilly and Company | 532457108 | COM | 20,700 | $16,136,271 | dollars as filed | put |
| Amgen Inc. | 031162100 | COM | 52,100 | $14,546,841 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 371,448 | $13,368,414 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 94,042 | $11,820,139 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 14,816 | $11,549,516 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 104,473 | $11,086,675 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 192,877 | $10,602,449 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 100,000 | $8,293,000 | dollars as filed | call |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 217,000 | $7,890,120 | dollars as filed | call |
| Eli Lilly and Company | 532457108 | COM | 10,000 | $7,795,300 | dollars as filed | call |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 200,000 | $7,358,000 | dollars as filed | call |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 100,200 | $7,354,680 | dollars as filed | put |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 100,000 | $6,902,000 | dollars as filed | call |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 156,300 | $6,788,109 | dollars as filed | call |
| VAXCYTE INC COM | 92243G108 | Stock | 198,285 | $6,446,245 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 131,400 | $5,673,852 | dollars as filed | call |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 112,000 | $5,447,680 | dollars as filed | call |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 50,000 | $5,306,000 | dollars as filed | call |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 197,468 | $5,232,902 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 280,700 | $4,898,215 | dollars as filed | call |
| ALTIMMUNE INC | 02155H200 | COM NEW | 1,262,900 | $4,887,423 | dollars as filed | call |
| Pfizer Inc. | 717081103 | COM | 200,000 | $4,848,000 | dollars as filed | call |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 123,300 | $4,483,188 | dollars as filed | put |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 10,000 | $4,452,000 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 76,185 | $4,210,745 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 122,100 | $4,061,046 | dollars as filed | call |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,317,600 | $3,570,696 | dollars as filed | call |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 698,400 | $3,533,904 | dollars as filed | call |
| Gilead Sciences,Inc. | 375558103 | COM | 30,000 | $3,326,100 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 5,974 | $3,292,988 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 104,384 | $3,275,570 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 5,607 | $2,943,675 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 79,079 | $2,909,316 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 102,100 | $2,816,939 | dollars as filed | call |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 392,213 | $2,816,089 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 100,000 | $2,759,000 | dollars as filed | put |
| ZYMEWORKS INC | 98985Y108 | COM | 179,300 | $2,250,215 | dollars as filed | call |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 62,926 | $2,228,839 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 206,200 | $2,055,814 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 150,000 | $2,055,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 53,985 | $1,962,895 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 41,300 | $1,949,360 | dollars as filed | put |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 519,900 | $1,944,426 | dollars as filed | call |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 88,900 | $1,917,573 | dollars as filed | call |
| SCPHARMACEUTICALS INC | 810648105 | COM | 486,500 | $1,853,565 | dollars as filed | call |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 122,061 | $1,706,413 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 74,700 | $1,589,616 | dollars as filed | call |
| Merck & Co.,Inc. | 58933Y105 | COM | 20,000 | $1,583,200 | dollars as filed | |
| Reviva Pharmaceuticals Holdings Inc | 76152G100 | Common Stock | 4,000,000 | $1,524,400 | dollars as filed | call |
| UNIQURE NV | N90064101 | SHS | 104,100 | $1,451,154 | dollars as filed | call |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 201,400 | $1,446,052 | dollars as filed | put |
| BIOHAVEN LTD | G1110E107 | COM | 100,000 | $1,411,000 | dollars as filed | call |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 58,926 | $1,408,331 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 136,700 | $1,268,576 | dollars as filed | call |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 253,657 | $1,080,579 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 50,000 | $1,064,000 | dollars as filed | put |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 106,600 | $1,058,538 | dollars as filed | put |
| Reviva Pharmaceuticals Holdings Inc | 76152G100 | Common Stock | 2,735,457 | $1,042,483 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 158,536 | $1,028,899 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 568,900 | $1,024,020 | dollars as filed | call |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 200,000 | $1,024,000 | dollars as filed | call |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 185,830 | $1,016,490 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 824,800 | $1,014,504 | dollars as filed | call |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 259,852 | $969,248 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 98,382 | $966,111 | dollars as filed | |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 400,000 | $876,000 | dollars as filed | call |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 702,135 | $870,647 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 217,623 | $829,144 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 403,922 | $807,844 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 131,400 | $752,922 | dollars as filed | call |
| ARVINAS INC | 04335A105 | COM | 96,455 | $709,909 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 171,400 | $663,318 | dollars as filed | put |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 208,100 | $655,515 | dollars as filed | call |
| ATYR PHARMA INC | 002120202 | COM NEW | 128,700 | $652,509 | dollars as filed | call |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 100,000 | $607,000 | dollars as filed | call |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 160,900 | $600,157 | dollars as filed | call |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 10,572 | $459,142 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 40,294 | $386,419 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 76,200 | $386,334 | dollars as filed | put |
| NUVALENT INC COM | 670703107 | Stock | 5,000 | $381,500 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 266,023 | $372,432 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 157,694 | $321,696 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 32,483 | $301,767 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 64,613 | $175,101 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 43,616 | $150,911 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 362,935 | $133,233 | dollars as filed | |
| PURETECH HEALTH PLC | 746237106 | ADS | 7,324 | $126,339 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 39,400 | $106,774 | dollars as filed | put |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 47,474 | $85,871 | dollars as filed | call |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 6,900 | $49,542 | dollars as filed | call |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 932 | $19,833 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 3,785 | $13,236 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 200 | $400 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892688-25-000149 | this filing | 2025-08-14 | acceptance time not in the bulk data set |